|
|
|
| home > white papers > Nanoparticle Tracking Analysis. A Review of Applications and Usage in the Analysis of Exosomes and Microvesicles - NanoSight |
|
|
 WHITE PAPERS |
|
NanoSight
|
|
Nanoparticle Tracking Analysis. A Review of Applications and Usage in the Analysis of Exosomes and Microvesicles
|
|
The study of exosomes and other cell-derived microvesicles is
an area of rapidly growing importance and the subject of intense interest and
research. The previous lack of suitable methods for their detection, analysis,
enumeration and phenotyping is proving to be a significant limitation in these
studies. This mini-review shows the degree to which the technique of
Nanoparticle Tracking Analysis (NTA) is helping to address these problems.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
£1 Billion Savings Opportunity and Value to the UK Economy from SBRI Healthcare Innovation Programme
An NHS England funded
initiative to develop products that address unmet health needs, today
released its annual report that shows how the programme has created a
pipeline of innovations that could bring the NHS £1 billion of savings.
More info >> |
|
 |
White Papers |
 |
|
Working Towards a Standardised Identification Solution
PCI Pharma Services
The security of the pharmaceutical supply chain is an issue of growing concern, with recent reports addressing its vulnerability to counterfeiting. The complexity of the European supply chain is one of the key factors of this counterfeiting pandemic, with millions of medicine packs being moved around the EU, annually. Aside from this, fragmentation has resulted in decreased transparency in the supply chain and increased difficulties to track and trace medicines, leading to significant threat from counterfeiting. As a key source of income for the European economy, it is essential that the supply chain remains safe and free of counterfeits. A significant stumbling block within the industry remains to be the lack of a unified, single‐source pan‐European or indeed global database where scanned bar codes on drug packaging can be verified at point of dispense. At some point in the future the pharmaceutical industry, regulatory bodies, clinicians and retailers will need to join forces to overcome this.
More info >> |
|
 |
Industry Events |
 |
7th annual Orphan Drugs and Rare Diseases UK
18-19 October 2017, Holiday Inn Kensington Forum, London
SMi Group is thrilled to present the 7th annual Orphan Drugs and Rare Diseases conference, taking place on 18th & 19th October 2017 in Central London, UK. This year’s theme will be focused towards discussing strategies for patient engagement, market access and gene therapies to enhance rare diseases and orphan drug research.
More info >> |
|
|
|
